Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation: Authors' reply

W. R. Kim, S. K. Asrani

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)616-617
Number of pages2
JournalAlimentary Pharmacology and Therapeutics
Volume33
Issue number5
DOIs
StatePublished - Mar 1 2011

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Cite this